| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Shu Ye | Q43073592 |
| P2093 | author name string | Shu Ye | |
| P433 | issue | 3 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 636-645 | |
| P577 | publication date | 2005-08-24 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome | |
| P478 | volume | 69 |
| Q54243049 | A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. |
| Q34796034 | A glimpse of matrix metalloproteinases in diabetic nephropathy |
| Q86016956 | A microRNA-520 mirSNP at the MMP2 gene influences susceptibility to endometriosis in Chinese women |
| Q53298349 | A modified technique improved histology similarity to human intracranial aneurysm in rabbit aneurysm model. |
| Q26825571 | A review of genetics, arterial stiffness, and blood pressure in African Americans. |
| Q28082608 | Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9 |
| Q33548692 | Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB |
| Q26830657 | Aneurysms of the ascending aorta |
| Q38696001 | Aneurysms of the ascending aorta and aortic arch |
| Q35158307 | Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis |
| Q64104030 | Association of Matrix Metalloproteinase 9 () Polymorphisms with Asthma Risk: A Meta-Analysis |
| Q35709244 | Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis |
| Q49990739 | Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development |
| Q36947473 | Associations of MMP1, 3, 9 and TIMP3 genes polymorphism with isolated systolic hypertension in Chinese Han population |
| Q44437504 | Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis. |
| Q35583154 | Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis |
| Q92599834 | Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 2: Pluridisciplinary perspective on their genetic and molecular origins |
| Q34584572 | Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy |
| Q40584963 | Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia |
| Q54337787 | Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia. |
| Q36802414 | Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke |
| Q54230919 | Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer. |
| Q56891358 | Genes Predisposing to Rapid Aneurysm Growth |
| Q37322723 | Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT. |
| Q36689091 | Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age |
| Q35762003 | Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. |
| Q30427166 | Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes |
| Q37355473 | Genetics and pathophysiology of arterial stiffness |
| Q38102604 | Heart failure in China: a review of the literature |
| Q52150418 | Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese. |
| Q33820443 | MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study |
| Q36870207 | MMP3 and TIMP2 gene variants as predisposing factors for Achilles tendon pathologies: Attempted replication study in a British case-control cohort |
| Q33974398 | Matrix Metalloproteinase-9 Level and Gene Polymorphism in Sleep Disordered Breathing Patients with or without Cardiovascular Disorders |
| Q33705804 | Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients |
| Q34566423 | Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk |
| Q39293550 | Matrix metalloproteinase family polymorphisms and the risk of aortic aneurysmal diseases: A systematic review and meta-analysis |
| Q43593047 | Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome |
| Q36985141 | Matrix metalloproteinase-9 Gene-1562C>T Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis of 5468 Subjects |
| Q37559372 | Matrix metalloproteinases and peripheral arterial disease |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q47817958 | Molecular pathology of total knee arthroplasty instability defined by RNA-seq |
| Q55057199 | N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling. |
| Q34016378 | Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines |
| Q34009450 | Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension |
| Q34238445 | Prediction of metalloproteinase family based on the concept of Chou's pseudo amino acid composition using a machine learning approach |
| Q33658683 | Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women |
| Q34784921 | Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells |
| Q54346624 | Role of matrix metalloproteinase 3 gene promoter polymorphism in chronic pancreatitis. |
| Q33620544 | Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients |
| Q36000924 | Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway |
| Q37835915 | Signaling events in pathogen-induced macrophage foam cell formation |
| Q33635570 | Single nucleotide polymorphism-specific regulation of matrix metalloproteinase-9 by multiple miRNAs targeting the coding exon |
| Q42050945 | The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis |
| Q41553156 | The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions |
| Q37116230 | The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. |
| Q39373216 | Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells |
Search more.